This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
PEACE-3 Trial
PROfound Trial
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
VISION Trial
mHSPC
ARANOTE Trial
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
COBRA Trial
CONDOR Trial
OSPREY Trial
Bladder Cancer
ADSTILADRIN
ANKTIVA
Bladder Cancer Detection
CORE-001 Study
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Ruchika Talwar, MD
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Shilpa Gupta, MD
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Jaime Landman, MD
Prostate Cancer
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
Decipher Genomic Classifier
Imaging Center
Phillip Koo, MD
mHSPC
Neeraj Agarwal, FASCO, MD
nmCRPC
Zachary Klaassen, MD, MSc
mCRPC Treatment
A. Oliver Sartor, MD
PSMA-Targeted Therapy
Advanced Prostate Cancer
Zachary Klaassen, MD, MSc
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular Cancer
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Pelvic Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Medical Education
Covid-19
The Prostate Cancer Foundation
Health Policy in Urological Diseases
Disparities: Social Determinants of Health
Practice Guidelines Reviews
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Pelvic Health & Reconstruction
Pelvic Health & Reconstruction
Trials in Progress
Trials in Progress
Bladder Cancer
IMMORTAL
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Middle Side
Prostate Cancer
ARAMON
ARASEC
ARASTEP
CLARIFY
ECLIPSE
ESCAPE
FORT
Right Side
Prostate Cancer
METANOVA
NRG-GU 0101
PROMISE
RTIRE
SECuRE
SHORTER
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
SCS AUA 2024
ASTRO 2024
IBCN 2024
ESMO 2024
BCAN TT 2024
All Conferences
View All
Quick Takes
ESMO 2024
PCF
UroToday Home
Recent Abstracts
Urologic Oncology
Prostate Cancer
Recent Abstracts
AUA 2011 - Suprapubic vs. urethral catheter drainage following robot assisted radical prostatectomy: A matched analysis - Session Highlights
May 21, 2011
AUA 2011 - Late breaking news: Denosumab to prevent bone metastases (Dmab 147 Study) - Session Highlights
May 19, 2011
AUA 2011 - State-of-the-art lecture: Imaging and the treatment of nodal disease in bladder and prostate cancer - Session Highlights
May 19, 2011
AUA 2011 - State-of-the-art lecture: What is new in PSA based screening for prostate cancer - An update of the ERSPC study - Session Highlights
May 19, 2011
AUA 2011 - State-of-the-art lecture: Prostate cancer susceptibility genes - Session Highlights
May 19, 2011
AUA 2011 - State-of-the-art lecture: Risks of imaging and monitoring patients with urologic cancers - Session Highlights
May 19, 2011
AUA 2011 - Effect of long-acting testosterone injections for treatment of hypogonadism after brachytherapy for prostate cancer - Session Highlights
May 19, 2011
AUA 2011 - Exploratory efficacy analysis conducted for long-term extension study in patients with prostate cancer treated with Firmagon® or crossed over to Firmagon from leuprolide - Press Release
May 19, 2011
AUA 2011 - The VA/NCI/AHRQ CSP#407: Prostate Cancer Intervention Versus Observation Trial (PIVOT): Main results from a randomized trial comparing radical prostatectomy to watchful waiting in men with clinically localized prostate cancer - Session Highligh
May 19, 2011
AUA 2011 - Content and construct validation of robotic surgery curriculum using electromagnetic instrument tracker - Session Highlights
May 18, 2011
AUA 2011 - Value of early confirmatory biopsies and centralized pathological review to select prostate cancer patients for active surveillance - Session Highlights
May 18, 2011
AUA 2011 - Long term complications in men after radical prostatectomy who have early or late radiation - Session Highlights
May 18, 2011
AUA 2011 - 5-alpha reductase inhibitors diminish the rate of progression in men with low risk prostate cancer on active surveillance - Session Highlights
May 18, 2011
AUA 2011 - Age and aggressive prostate cancer in patients with low risk characteristics. Implications for conservative management - Session Highlights
May 18, 2011
AUA 2011 - Previously developed systems-based biopsy model (Prostate Px+) identifies favorable-risk prostate cancer for men enrolled in an active surveillance program - Session Highlights
May 18, 2011
AUA 2011 - Effect of radical prostatectomy on penile shortening - Session Highlights
May 18, 2011
AUA 2011 - Characterization of ureter, bladder, and bowel tissue injury after compression with robotic instruments - Session Highlights
May 18, 2011
AUA 2011 - Postoperative pain after pure and robot-assisted laparoscopic radical prostatectomy. A prospective randomized study - Session Highlights
May 18, 2011
AUA 2011 - Abiraterone acetate plus low-dose prednisone has a favorable safety profile, improves survival and produces PSA and radiographic responses in metastatic castration-resistant prostate cancer progressing after docetaxel-based chemotherapy: Result
May 17, 2011
AUA 2011 - Regulatory role of miR-203 in prostate cancer progression and metastasis - Session Highlights
May 17, 2011
Page 1399 of 1438
Start
Prev
1394
1395
1396
1397
1398
1399
1400
1401
1402
1403
Next
End
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free